Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: results from the CREDENCE trial and meta-analysis
Zhou Z, Jardine MJ, Li Q, et al.
Stroke. 2021;52(5):1545-1556
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Zhou Z, Jardine MJ, Li Q, et al.
Stroke. 2021;52(5):1545-1556
Leggi
Shapiro ALB, Dabelea D, Stafford JM, et al.
Diabetes Care. 2021;dc202308.
Leggi
Kernan WN, Inzucchi SE
Stroke. 2021;52(5):1557-1560
Leggi
Adler A, Agodoa L, Algra A, et al.
The Lancet. Pub. online 1 May 2021
Leggi
Enebo LB, Berthelsen KK, Kankam M, et al.
The Lancet. Pub. online 22 April 2021
Leggi
Becerril S, Frühbeck G
The Lancet. Pub. online 22 April 2021
Leggi
Powell EE, Wai-Sun Wong V, Rinella M
The Lancet. Pub. online 21 April 2021
Leggi
Khazai B, Adabifirouzjaei F, Guo M, et al.
The American Journal of Cardiology. Pub. online 20 April 2021
Leggi
Holtermann A, Schnohr P, Nordestgaard BG, Marott JL
Eur Heart J. 2021;42(15):1499-1511
Leggi
Mariam A, Miller-Atkins G, Pantalone KM, et al.
Diabetes Care. 2021;dc202700.
Leggi